Editorials – Genomes to People

Defining and pursuing diversity in human genetic studies

Raven-Adams MC, Hernandez-Boussard T, Joly Y, Knoppers BM, Chandrasekharan S, Thorogood A, Kumuthini J, Loon Ho CW, Gonzalez A, Nelson SC, Bombard Y, Thaldar D, Liu H, Costa A, Muralidharan V, Henriques S, Nasir J, Lumaka A, Kaiser B, Jamuar SS, Lewis ACF

Nature Genetics September 2024

Ready or not, genomic screening of fetuses is already here

Gold NB, Nadel A, Green RC

Genetics in Medicine January 2024

Prioritizing the detection of rare pathogenic variants in population screening

Lacaze P, Manchanda R, Green RC

Nature Reviews Genetics January 2023

Population DNA screening for medically actionable disease risks in adults

Lacaze PA, Tiller J, Winship I, Brotchie A, McNeil J, Zalcberg J, Thomas D, Milne R, James P, Delatycki M, Young M, Nowak K, Nguyen-Dumont T, Southey M, Ademi Z, Bruinsma F, Riaz M, Terrill B, Kirk J, Tucker K, Andrews L, Pachter N, Susman R, Poplawski N, Wallis M, Watts G, Nicholls S, Macrae F, Sturm A, Green RC, Ahern S, Von Saldern S, Powell S, Rice T

Medical Journal of Australia March 2022

Re-evaluating the “right not to know” in genomics research

Gold NB, Green RC

Genetics in Medicine November 2021

How will Aducanumab approval impact Alzheimer’s disease research?

Weiner MW, Aisen PS, Beckett LA, Green RC, Jagust William, Morris JC, Okonkwo O, Perrin RJ, Petersen RC, Mindt MR, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ and the Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Journal of Prevention of Alzheimer's Disease July 2021

An international policy on returning genomic research results

Lewis ACF, Knoppers BM, Green RC

Genome Medicine July 2021

Long-awaited progress in addressing genetic discrimination in the US

Lewis ACF, Green RC, Prince AER

Genetics in Medicine October 2020

Physicians and patient holding roadmap with DNA helix

Genetic testing, insurance discrimination, and medical research: What the US can learn from peer countries

Bélisle-Pipon JC, Vayena E, Green RC, Cohen IG

Nature Medicine August 2019

Minding the aging brain: Are we ready for personalized medicine?

Karlawish J, Green RC.

American Journal of Psychiatry February 2014

Genomic medicine in the military

De Castro M, Biesecker LG, Turner C, Brenner R, Witkop C, Mehlman M, Bradburne C, Green RC

Genomic Medicine January 2016

GINA, genetic discrimination, and genomic medicine

Green RC, Lautenbach D, McGuire AL

New England Journal of Medicine January 2015

How behavioral economics can help to avoid ‘The last mile problem’ in whole genome sequencing

Blumenthal-Barby J, McGuire AL, Green RC, Ubel PA.

Genome Medicine January 2015

Regulation: The FDA is overcautious on consumer genomics

Green RC, Farahany NA.

Nature January 2014

Genomic medicine in primary care: Barriers and assets

Vassy JL, Green RC, Lehmann LS

Postgraduate Medical Journal October 2013

Reporting genomic sequencing results to ordering clinicians: Incidental, but not exceptional

Green RC, Lupski JR, Biesecker LG.

Journal of the American Medical Association July 2013

Point-counterpoint ethics and genomic incidental findings

McGuire AL, Joffe S, Koenig B, Biesecker B, McCullough LB, Blumenthal-Barby J, Caulfield T, Terry SF, Green RC.

Science June 2013

How could disclosing incidental information from whole-genome sequencing affect patient behavior?

Christensen KD, Green RC

Personalized Medicine June 2013

Research results: Preserving newborn blood samples

Lewis MH, Scheurer ME, Green RC, McGuire AL.

Science Translational Medicine November 2012

The future of direct-to-consumer clinical genetic tests

Frueh FW, Greely HT, Green RC, Hogarth S, Siegel S.

Nature Reviews Genetics June 2011

Direct to consumer genetic testing: Avoiding a culture war

Evans JP, Green RC.

Genetics in Medicine July 2009